XNAS
SYRA
Market cap969kUSD
Jun 06, Last price
0.08USD
1D
-18.80%
1Q
-79.34%
IPO
-97.32%
Name
Syra Health Corp
Chart & Performance
P/E
—
P/S
0.12
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
8m
+44.73%
Net income
-4m
L+27.94%
CFO
-3m
L+6.27%
Profile
Syra Health Corp., a healthcare services company, provides health education, population health management, behavioral and mental health, healthcare workforce, and digital health services in the United States. It offers health education services, including medical communications, patient education, and healthcare training; and population health management services, such as analytics as a service, epidemiology, and health equity analytics solutions. The company also engages in developing Syrenity, an on-demand telehealth platform for mental health services. In addition, the company provides healthcare staffing solutions; and digital health solutions comprising digital transformation, cloud and security, artificial intelligence, patient engagement, and health apps. It serves mental health hospitals and organizations, including government agencies, integrated health networks, managed care entities, and pharmaceutical manufacturers. Syra Health Corp. was incorporated in 2020 and is headquartered in Carmel, Indiana.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | |
| Income | |||||
Revenues | 7,982 44.73% | 5,515 -1.83% | 5,618 298.43% | ||
Cost of revenue | 8,359 | 8,351 | 8,052 | ||
Unusual Expense (Income) | |||||
NOPBT | (377) | (2,835) | (2,434) | ||
NOPBT Margin | |||||
Operating Taxes | 63 | ||||
Tax Rate | |||||
NOPAT | (377) | (2,835) | (2,434) | ||
Net income | (3,759) 27.94% | (2,938) 38.72% | (2,118) 64,478.20% | ||
Dividends | |||||
Dividend yield | |||||
Proceeds from repurchase of equity | 2,469 | 5,332 | 2,322 | ||
BB yield | -82.52% | -107.63% | |||
| Debt | |||||
Debt current | 265 | 311 | 872 | ||
Long-term debt | 486 | 63 | 247 | ||
Deferred revenue | |||||
Other long-term liabilities | |||||
Net debt | (1,644) | (2,906) | 1,116 | ||
| Cash flow | |||||
Cash from operating activities | (2,932) | (2,759) | (2,244) | ||
CAPEX | (11) | (15) | (121) | ||
Cash from investing activities | (11) | (15) | (121) | ||
Cash from financing activities | 2,058 | 6,051 | 2,269 | ||
FCF | (268) | (2,834) | (3,338) | ||
| Balance | |||||
Cash | 2,395 | 3,280 | 3 | ||
Long term investments | |||||
Excess cash | 1,996 | 3,004 | |||
Stockholders' equity | (8,814) | (5,059) | (2,122) | ||
Invested Capital | 12,145 | 9,383 | 3,748 | ||
ROIC | |||||
ROCE | |||||
| EV | |||||
Common stock shares outstanding | 7,265 | 4,878 | 7,282 | ||
Price | 0.41 -59.45% | 1.02 | |||
Market cap | 2,992 -39.60% | 4,954 | |||
EV | 1,348 | 2,049 | |||
EBITDA | (315) | (2,787) | (2,420) | ||
EV/EBITDA | |||||
Interest | 16 | 54 | 29 | ||
Interest/NOPBT | |||||